OLANZAPINE 5mg. IP

An antipsychotic medication that is indicated for use in the treatment of schizophrenia and other psychotic disorders. Offers an effective alternative for treating schizophrenia and reduces the negative symptoms of schizophrenia (K A Bever, 1998) A safe and effective treatment for anxiety in cognitively impaired patients. (Rita Moretti, 2004) Improves the general mental state more than some second-generation antipsychotic drugs, namely aripiprazole, quetiapine, risperidone, and ziprasidone. (Katja Komossa, 2010) A first-line option in the management of schizophrenia in the acute phase and for the maintenance of treatment response. (N Bhana, 2001) An effective first-line or adjunctive agent for the acute treatment of manic episodes. (Paul L McCormack, 2004) Effectively treats psychotic and behavioral disturbances associated with Alzheimer's disease. (Schatz, 2003) A suitable approach for the long-term prevention of relapse into manic, depressive, or mixed episodes associated with bipolar I disorder. (Paul L McCormack, 2004) Promotes rapid weight gain and improvement in obsessive symptoms among patients with anorexia nervosa. (Hany Bissada, 2008) Demonstrates superior antipsychotic efficacy compared with haloperidol in the treatment of acute phase schizophrenia. (N Bhana, 2001) More efficacious than quetiapine in several measures of the general mental state and positive symptoms. (Katja Komossa, 2010) More effective than risperidone in the improvement of negative symptoms in older patients with schizophrenia. (Gilanipoor, 2014)